<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="table1" position="float"><object-id pub-id-type="doi">10.7554/eLife.26693.005</object-id><label>Table 1.</label><caption><title>Biochemical IC<sub>50</sub> values of MELK inhibitors.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top"/><th colspan="5" valign="top">Biochemical IC<sub>50</sub> (nM)</th></tr><tr><th valign="top"/><th valign="top">MELK*</th><th valign="top">PIK3CA<sup>&#8224;</sup></th><th valign="top">mTOR*</th><th valign="top">GSK3A*</th><th valign="top">CDK7<sup>&#8224;</sup></th></tr></thead><tbody><tr><td valign="top">JW-7-25-1</td><td valign="top">5.0</td><td valign="top"/><td valign="top">5.5</td><td valign="top">12.3</td><td valign="top">63.4</td></tr><tr><td valign="top">HTH-01-091</td><td valign="top">10.5</td><td valign="top">962</td><td valign="top">632</td><td valign="top">1740</td><td valign="top">1230</td></tr><tr><td valign="top">OTSSP167</td><td valign="top">0.5</td><td valign="top">66.5</td><td valign="top">35.7</td><td valign="top">1.6</td><td valign="top">49.1</td></tr><tr><td valign="top">MRT199665</td><td valign="top">1.4&#8211;3.3</td><td valign="top"/><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">NVS-MELK8a</td><td valign="top">11.9</td><td valign="top"/><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">MELK-T1</td><td valign="top">13.5</td><td valign="top"/><td valign="top"/><td valign="top"/><td valign="top"/></tr></tbody></table><table-wrap-foot><fn><p>*Kinase activity measured by Z&#8217;-LYTE assay at [ATP]=apparent Km, in accordance with Z&#8217;-LYTE Screening Protocol and Assay Conditions provided by Life Technologies.</p><p><sup>&#8224;</sup>Kinase activity measured by Adapta assay at [ATP]=apparent Km, in accordance with Adapta Screening Protocol and Assay Conditions provided by Life Technologies.</p></fn></table-wrap-foot></table-wrap>